Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.
The Australian Competition and Consumer Commission will not sign off on Transurban’s plan to acquire a majority stake in fellow toll road operator Horizon Roads, finding the deal would likely reduce competition for toll road concessions in Victoria.
A battle with the competition regulator over the proposed ANZ, Suncorp tie-up has begun, with the first clash involving a group of rival lenders that want their submissions to the ACCC kept under lock and key.
The ACCC has delayed its decision on whether to greenlight Coles’ plans to acquire milk processing plants from Saputo, after expressing competition concerns about the $105 million deal.
Clifford Chance has snagged an M&A partner from Herbert Smith Freehills to join its growing corporate practice.
Global law firm Jones Day has recruited two partners for its growing energy practice, including a former Ashurst partner.
ASIC wants to re-run its case against investment group M101 Nominees and founder James Mawhinney after admitting it made errors at its initial trial, arguing for new fines and disqualification orders on remittal by the Full Court, a judge has heard.
The corporate regulator has lost its civil case against Frank Wilson, the founder of sandalwood oil producer Quintis, after failing to persuade the Federal Court he withheld from the board the termination of major supply contracts with a Nestle unit.
A judge has refused infant formula company Care A2’s bid to block US business partner Gensco from filing a lawsuit in Florida that overlaps with a $200 million suit filed in Australian court over a deal to sell formula in the US amid a supply shortage.
ANZ has lodged an application asking the Australian Competition Tribunal to reverse the competition regulator’s rejection of its $4.9 billion tie-up with Queensland-based Suncorp.